Age, Biography and Wiki

David Rees (organic chemist) was born on 1958. Discover David Rees (organic chemist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 65 years old?

Popular As N/A
Occupation N/A
Age 65 years old
Zodiac Sign
Born 1958
Birthday 1958
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 1958. He is a member of famous with the age 65 years old group.

David Rees (organic chemist) Height, Weight & Measurements

At 65 years old, David Rees (organic chemist) height not available right now. We will update David Rees (organic chemist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

David Rees (organic chemist) Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is David Rees (organic chemist) worth at the age of 65 years old? David Rees (organic chemist)’s income source is mostly from being a successful . He is from . We have estimated David Rees (organic chemist)'s net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

David Rees (organic chemist) Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2020

Rees is associated with the discovery of three launched drugs: ribociclib (Astex-Novartis collaboration), erdafitinib (Astex-Janssen collaboration) as well as the anaesthetic reversal agent sugammadex (Organon, Merck), which has been used in over 30 million patients in 60 countries and had global sales of US$1.2 billion in 2020.

Rees has held visiting professorships at three UK universities, and sits on several scientific advisory boards for not-for-profit organisations. In 2020 he was elected as a Fellow of the Academy of Medical Sciences and inducted into the RSC BMCS Hall of Fame. He has over 140 publications and patents.

2010

David is a Fellow of the Royal Society of Chemistry (RSC). He is one of the few industrial scientists to have served as President of its Organic Division (2010-2013), and was later elected to the RSC Board of Trustees (2015-2019).

2003

David joined Astex in 2003 to lead its chemistry team. He became Chief Scientific Officer (CSO) in 2017.  In 2013, Astex was acquired for around USD $900 million and now operates as a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd, headquartered in Tokyo, Japan.

1958

David Charles Rees (born 1958) CChem FRSC FMedSci is a chemist recognised internationally for his innovative use of chemistry in drug discovery. He is Chief Scientific Officer of biotechnology company Astex Pharmaceuticals, which is located in Cambridge, UK.